TreeFrog Therapeutics, a French biotech focused on bringing regenerative medicine to millions through its proprietary cell technology, C-Stem, has appointed Mark Rothera, as Chief Executive Officer and Board member. Rothera succeeds Frédéric Desdouits, who is stepping down after five years in the role. In the new leadership configuration, co-founders Kévin Alessandri and Maxime Feyeux will transition from daily operations to focus on their roles on the Board. Elsy Boglioli, Chair of the Bo...